Portal de investigação
Polymorphisms and haplotypes of TOLLIP and MUC5B are associated with susceptibility and survival in patients with fibrotic hypersensitivity pneumonitis.
Autores da FMUP
Participantes de fora da FMUP
- Mota, PC
- Ferreira, AC
- Santos, RF
- Rufo, JC
- Vasconcelos, D
- Carvalho, A
- Guimarães, S
- Vasques Nóvoa, F
- Cardoso, C
- Melo, N
- Alexandre, AT
- Coelho, D
Unidades de investigação
Abstract
Filiações
Filiações não disponíveis
Proyectos asociados
Fibrosing ILD Biomarkers That Rule Acceleration (FIBRALUNG) -NCT05635032
Investigador Principal: Hélder Novais e Bastos
Estudo Observacional Académico (FIBRALUNG) . FCT . 2021
MCP1 as a prognostic biomarker in Hypersensitivity Pneumonitis: a prospective study
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico (Pneumonitis) . 2023
Chronic Bronchopulmonary aspergillosis patients with underlying chronic obstructive pulmonary disease: providing grounds for biomarkers search through clinical phenotyping
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2020
Impact of Chronic Obstructive Pulmonary Disease in surgical outcomes of lung cancer patients undergoing curative intent surgery
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2021
Pulmonary Emphysema Regional Distribution and Extent from Chest Computed Tomography is Associated with Pulmonary Function Impairment in COPD Patients.
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2021
Non-invasive assessment of Benign Tracheal Stenosis.
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2020
Predictors of lung entrapment in malignant pleural effusion
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2022
Citar a publicação
Mota PC,Soares ML,Ferreira AC,Santos RF,Rufo JC,Vasconcelos D,Carvalho A,Guimarães S,Vasques F,Cardoso C,Melo N,Alexandre AT,Coelho D,Novais H,Morais A. Polymorphisms and haplotypes of TOLLIP and MUC5B are associated with susceptibility and survival in patients with fibrotic hypersensitivity pneumonitis. Pulmonology. 2024. IF:11,700. (1).
